Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
FNA

FNA - Paragon 28, Inc. Stock Price, Fair Value and News

$15.40+0.90 (+6.21%)
Market Closed

33/100

FNA

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

33/100

FNA

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$11.44

Target 3M

$13.38

Target 6M

$12.53

FNA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

FNA Price Action

Last 7 days

13.2%

Last 30 days

8.5%

Last 90 days

17.6%

Trailing 12 Months

28.3%

FNA RSI Chart

FNA Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

FNA Valuation

Market Cap

1.1B

Price/Earnings (Trailing)

-20.48

Price/Sales (Trailing)

4.37

EV/EBITDA

-52.03

Price/Free Cashflow

-41.23

FNA Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$11.44

Target 3M

$13.38

Target 6M

$12.53

FNA Fundamentals

FNA Revenue

FNA Earnings

FNA Profitability

Free Cashflow Yield

-2.43%

FNA Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024225.4M235.4M245.0M256.2M
2023192.0M200.6M207.3M216.4M
2022155.7M162.5M172.7M181.4M
2021120.1M129.2M138.3M147.5M
202000108.6M111.0M
2019000106.3M
Get all data in R, Python etc through our Historical Stock Data APIs

About Paragon 28, Inc.

FNA
Paragon 28, Inc. designs, develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems. The company also provides precision guide technology for various procedures consisting of fusion, a procedure to address bunion deformities that fuses two bones on the big toe; first tarsometatarsal arthrodesis; and metatarsal osteotomy for bunion correction, medial column beaming for charcot foot reconstruction, ankle fusion plating, and NC joint arthrodesis. In addition, it offers monster, mini monster, and joust beaming screw systems for use in bone reconstruction, osteotomy, arthrodesis, joint fusion, ligament fixation, fracture repair, and fracture fixation; APEX 3D total ankle replacement systems; and total talus spacers to replace the talus and bone in the ankle that connects the leg and foot. Further, the company provides forefoot or hallux valgus correction systems, including phantom intramedullary nail systems for the treatment of severe hallux valgus; and various orthobiologics comprising bone wedges, grafts, demineralized bone matrices, bone void fillers, synthetic materials, amniotic products, and a biocompatible collagen matrix, as well as PRESERVE bone graft systems for homologous application. Additionally, it offers soft tissue fixation systems, titanium sprayed polyetheretherketone implants, nitinol staple systems, stabilization systems, and curved instruments. The company serves hospitals and ambulatory surgery centers through a network of sales representatives and stocking distributors. Paragon 28, Inc. was founded in 2010 and is headquartered in Englewood, Colorado.
 CEO
 WEBSITEparagon28.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES463

Paragon 28, Inc. Frequently Asked Questions

FNA is the stock ticker symbol of Paragon 28, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Paragon 28, Inc. is 1.09 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check FNA's fair value in chart for subscribers.

The fair value guage provides a quick view whether FNA is over valued or under valued. Whether Paragon 28, Inc. is cheap or expensive depends on the assumptions which impact Paragon 28, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for FNA.

As of Wed Jan 28 2026, FNA's PE ratio (Price to Earnings) is -20.48 and Price to Sales (PS) ratio is 4.37. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. FNA PE ratio will change depending on the future growth rate expectations of investors.